Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30894534 | 1.00 | NAAA (0.56) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL10467609 | 1.00 | NAAA (0.56) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL9743615 | 1.00 | NAAA (0.56) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL30894533 | 0.99 | NAAA (0.55) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL453206 | 0.99 | NAAA (0.54) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL1232050 | 0.95 | NAAA (0.66) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL1938967 | 0.95 | NAAA (0.51) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL20194432 | 0.95 | NAAA (0.66) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL27477147 | 0.93 | NAAA (0.49) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL580975 | 0.93 | NAAA (0.45) | NAAASMN1; SMN2KMT2AMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 484 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6391949-B1 | — | — | None | — | — | US | claimed |
| EP-3841166-B2 | STABILIZED ROTOMOLDED POLYOLEFIN | BASF SE (DE) | 2025-05-07 | — | — | EP | claimed |
| EP-3565861-B1 | PHOTOCURABLE HARDCOAT COMPOSITIONS, METHODS, AND ARTICLES DERIVED THEREFROM | BASF SE (DE) | 2023-06-21 | — | — | EP | claimed |
| US-11623979-B2 | Stabilized polyolefin compositions comprising benzofuranones and hindered amine light stabilizers | BASF SE (DE) | 2023-04-11 | — | — | US | claimed |
| US-20220282064-A1 | STABILIZER COMPOSITION | BASF SE (DE) | 2022-09-08 | — | — | US | claimed |
| US-20220259405-A1 | Stabilized Polyolefin Compositions Comprising Benzofuranones and Hindered Amine Light Stabilizers | BASF CORPORATION | 2022-08-18 | — | — | US | claimed |
| CN-110352223-B | Coating composition with covalently bound UV absorber | 巴斯夫欧洲公司 | 2022-08-02 | — | — | CN | claimed |
| EP-3841166-B1 | STABILIZED ROTOMOLDED POLYOLEFIN | BASF SE (DE) | 2022-07-20 | — | — | EP | claimed |
| EP-4004099-A1 | STABILIZER COMPOSITION | BASF SE (DE) | 2022-06-01 | — | — | EP | claimed |
| CN-112608516-B | Multifunctional light-stable composition and preparation method thereof | 沈阳化工研究院有限公司 | 2022-04-08 | — | — | CN | claimed |
| US-20010031872-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-10-18 | — | — | US | claimed |
| US-6296674-B1 | Candle wax stabilized with red-shift benzotriazoles | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-10-02 | — | — | US | claimed |
| US-20010018520-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-08-30 | — | — | US | claimed |
| WO-2001057126-A1 | CANDLE WAX STABILIZED BY A COMBINATION OF UV ABSORBER PLUS A SELECTED HINDERED AMINE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-08-09 | — | — | WO | claimed |
| WO-2001057125-A1 | CANDLE WAX STABILIZED WITH RED-SHIFTED BENZOTRIAZOLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-08-09 | — | — | WO | claimed |
| US-6221115-B1 | WHITE, DYED, DIPPED, UNSCENTED AND/OR SCENTED CANDLE WAX STABILIZED BY A ULTRAVILET RADIATION ABSORBER AND HINDERED AMINE STABILIZING AGENT | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-04-24 | — | — | US | claimed |
| US-5844026-A | N,N',N''-tris{2,4-bis Hydrocarbyloxy-2,2,6,6-tetra-methylpiperidin-4-yl)alkylamino!-s-triazin-6-yl}-3,3'-ethylenediiminodipropylamines, their isomers and bridged derivatives and polymer compositions stabilized therewith | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-12-01 | — | — | US | claimed |
| EP-0309402-B1 | N-substituted hindered amine stabilizers | CIBA GEIGY AG (CH) | 1995-01-11 | — | — | EP | claimed |
| US-5204473-A | O-substituted N-hydroxy hindered amine stabilizers | CIBA-GEIGY CORPORATION (US) | 1993-04-20 | — | — | US | claimed |
| EP-0309402-A1 | N-substituted hindered amine stabilizers | CIBA-GEIGY AG (CH) | 1989-03-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010018520-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885SMN1; SMN2 595/4885KMT2A 617/4885 |
| US-20010031872-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885SMN1; SMN2 595/4885KMT2A 617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.